Corallo, F.; Sessa, E.; Rifici, C.; De Cola, M.C.; Di Cara, M.; Cardile, D.; Venuti, G.; Bonfiglio, N.; D’Aleo, G.; Quartarone, A.;
et al. Anxiety and Perception of Disease Control in Multiple Sclerosis Subjects Treated with Natalizumab. J. Clin. Med. 2024, 13, 13.
https://doi.org/10.3390/jcm13010013
AMA Style
Corallo F, Sessa E, Rifici C, De Cola MC, Di Cara M, Cardile D, Venuti G, Bonfiglio N, D’Aleo G, Quartarone A,
et al. Anxiety and Perception of Disease Control in Multiple Sclerosis Subjects Treated with Natalizumab. Journal of Clinical Medicine. 2024; 13(1):13.
https://doi.org/10.3390/jcm13010013
Chicago/Turabian Style
Corallo, Francesco, Edoardo Sessa, Carmela Rifici, Maria Cristina De Cola, Marcella Di Cara, Davide Cardile, Giuseppe Venuti, Noemi Bonfiglio, Giangaetano D’Aleo, Angelo Quartarone,
and et al. 2024. "Anxiety and Perception of Disease Control in Multiple Sclerosis Subjects Treated with Natalizumab" Journal of Clinical Medicine 13, no. 1: 13.
https://doi.org/10.3390/jcm13010013
APA Style
Corallo, F., Sessa, E., Rifici, C., De Cola, M. C., Di Cara, M., Cardile, D., Venuti, G., Bonfiglio, N., D’Aleo, G., Quartarone, A., & Lo Buono, V.
(2024). Anxiety and Perception of Disease Control in Multiple Sclerosis Subjects Treated with Natalizumab. Journal of Clinical Medicine, 13(1), 13.
https://doi.org/10.3390/jcm13010013
